Literature DB >> 15623432

Molecular and electrical characterization of the canine cardiac ventricular septum.

Christian Ramakers1, Milan Stengl, Roel L H M G Spätjens, Antoon F M Moorman, Marc A Vos.   

Abstract

Electrophysiological heterogeneity in the ventricular septum (VS) has been poorly addressed. In this study we investigated the electrophysiological and molecular composition of the VS in control sinus rhythm (SR) and chronic, complete atrio-ventricular block (CAVB) dogs. In the latter model, we anticipated that the increased inter-ventricular differences in action potential duration (APD; LV >RV) would accentuate the intrinsic heterogeneous composition of the VS. Steady-state mRNA levels of 10 important cardiac ion channels subunits as well as action potential (AP) characteristics (APD95, phase 1 amplitude (P1A), resting membrane potential) were measured in both sides of the VS excluding a small mid-myocardial strip (right: RVS, left: LVS). In SR, differences in steady-state mRNA between the two septal layers were observed for KChIP2 (approximately fivefold, P <0.01) and KCNQ1 (approximately twofold, P <0.05) with significantly higher levels of steady-state mRNA in the RVS compared to LVS. Correspondingly, shorter APDs and lower P1As (more spike and dome) were found in RVS, although the AP differences were subtle. This transseptal expression of KChIP2 and KCNQ1 corresponded with the observed differential expression levels in the right ventricle (RV) and left ventricular (LV) free wall, respectively. Electrical remodeling due to CAVB was also observed in the VS as was shown by approximately twofold lower levels in KCND3, KCNH2 and KCNQ1 mRNA (P <0.05) in the LVS compared to SR, thereby creating new or eliminating existing transseptal gradients. In parallel to changes in steady-state mRNA, CAVB resulted in a loss of the spike and dome morphology and longer APD95 (P <0.05) in the LVS. It is concluded that similar to other regions in the cardiac ventricles, the canine VS is molecularly and electrically heterogeneous. In the CAVB dog, this septal heterogeneity becomes accentuated as a result of electrical remodeling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623432     DOI: 10.1016/j.yjmcc.2004.10.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Development of a coronary-perfused interventricular septal preparation as a model for studying the role of the septum in arrhythmogenesis.

Authors:  Aaron Glass; Serge Sicouri; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

Review 2.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 3.  Cardiac resynchronization therapy for patients with congenital heart disease: technical challenges.

Authors:  Meera Manchanda; Christopher J McLeod; Ammar Killu; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2012-10-19       Impact factor: 1.900

4.  Differences in Left Versus Right Ventricular Electrophysiological Properties in Cardiac Dysfunction and Arrhythmogenesis.

Authors:  Cristina E Molina; Jordi Heijman; Dobromir Dobrev
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

Review 5.  MicroRNA regulation of cardiac conduction and arrhythmias.

Authors:  Gene H Kim
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

6.  Transseptal dispersion of repolarization and its role in the development of Torsade de Pointes arrhythmias.

Authors:  Serge Sicouri; Aaron Glass; Marcela Ferreiro; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2009-11-10

7.  Interventricular Differences in Action Potential Duration Restitution Contribute to Dissimilar Ventricular Rhythms in ex vivo Perfused Hearts.

Authors:  Balvinder S Handa; Saheed Lawal; Ian J Wright; Xinyang Li; Javier Cabello-García; Catherine Mansfield; Rasheda A Chowdhury; Nicholas S Peters; Fu Siong Ng
Journal:  Front Cardiovasc Med       Date:  2019-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.